Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02336165
Title Phase 2 Study of MEDI4736 in Patients With Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ludwig Institute for Cancer Research
Indications
Therapies
Age Groups: adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Facility Los Angeles California 90095 United States Details
Research Facility San Francisco California 94143 United States Details
Research Facility Baltimore Maryland 21287 United States Details
Research Facility Boston Massachusetts 02114 United States Details
Research Facility Boston Massachusetts 02215 United States Details
Research Facility Saint Louis Missouri 63110 United States Details
Research Facility New York New York 10065 United States Details
Research Facility Melbourne Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field